STELLA OKAH: Open Payments
NPI 1114523867 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,969 in 150 payments from 11 companies in 2025. Trend: 2023 $1,307 · 2024 $2,599 · 2025 $2,969
Food & beverage: $2,969
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 32 | $770 |
| ABBVIE INC. | 22 | $468 |
| Alkermes, Inc. | 13 | $411 |
| E.R. Squibb & Sons, L.L.C. | 31 | $361 |
| Janssen Pharmaceuticals, Inc | 10 | $252 |
| Vanda Pharmaceuticals Inc. | 13 | $195 |
| Braeburn Inc. | 13 | $195 |
| Teva Pharmaceuticals USA, Inc. | 8 | $154 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| Indivior Inc. | 4 | $62 |
Products named: CAPLYTA, VRAYLAR, COBENFY, ARISTADA, BRIXADI, INVEGA SUSTENNA, LYBALVI, HETLIOZ.
Industry payments across NJ — which companies pay providers there.
